Related Experiment Video
Updated: Mar 8, 2026

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
Published on: April 2, 2020
Two-Pore Channel Function Is Crucial for the Migration of Invasive Cancer Cells
Ong Nam Phuong Nguyen1, Christian Grimm2, Lina S Schneider1
1Department of Pharmacy, Pharmaceutical Biology, Ludwig-Maximilians-University Munich, Munich, Germany.
Abstract:
Metastatic invasion is the major cause of cancer-related deaths. In this study, we introduce two-pore channels (TPC), a recently described class of NAADP- and PI(3,5)P2-sensitive Ca2+-permeable cation channels in the endolysosomal system of cells, as candidate targets for the treatment of invasive cancers. Inhibition of the channel abrogated migration of metastatic cancer cells in vitro Silencing or pharmacologic inhibition of the two-pore channel TPC2 reduced lung metastasis of mammary mouse cancer cells. Disrupting TPC function halted trafficking of β1-integrin, leading to its accumulation in EEA1-positive early endosomes. As a consequence, invasive cancer cells were no longer able to form leading edges, which are required for adequate migration. Our findings link TPC to cancer cell migration and provide a preclinical proof of concept for their candidacy as targets to treat metastatic cancers. Cancer Res; 77(6); 1427-38. ©2017 AACR.
Insights
Two-pore channels (TPC) are potential targets for treating invasive cancers. Inhibiting TPC stops cancer cell migration and reduces metastasis by disrupting essential protein trafficking.
Area of Science:
- Cell Biology
- Oncology
- Ion Channel Physiology
Background:
- Metastatic invasion is a primary driver of cancer mortality.
- Two-pore channels (TPC) are Ca2+-permeable cation channels in the endolysosomal system.
- TPCs are sensitive to NAADP and PI(3,5)P2.
Purpose of the Study:
- To investigate two-pore channels (TPC) as potential therapeutic targets for invasive cancers.
- To determine the role of TPC in cancer cell migration and metastasis.
Main Methods:
- In vitro assays to assess cancer cell migration.
- Gene silencing and pharmacologic inhibition of TPC2 in mouse models.
- Analysis of β1-integrin trafficking and leading edge formation in cancer cells.
Main Results:
- Inhibition of TPC abrogated metastatic cancer cell migration in vitro.
- Silencing or inhibiting TPC2 reduced lung metastasis in mice.
- Disruption of TPC function led to β1-integrin accumulation in early endosomes, impairing leading edge formation and migration.
Conclusions:
- TPCs are linked to cancer cell migration and metastasis.
- TPCs represent a promising preclinical target for anti-metastatic cancer therapies.
Related Concept Videos
Cancer Cell Migration through Invadopodia
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Cell Migration
Cell Migration
Chemotaxis and Direction of Cell Migration
Role of Myosin in Cell Migration
Myosin II is a hexamer comprising two heavy chains with globular heads and coiled-coil tails, two regulatory light chains, and two essential light chains. The ATPase sites on the myosin heads hydrolyze ATP, and the released phosphate generates the force for contraction....

